Results 231 to 240 of about 37,893 (278)

OH2 oncolytic virus inhibits non-small-cell lung cancer metastasis via β-catenin pathway suppression. [PDF]

Commun Biol
Hu H, Shen Q, Zhang L, Zhu S, Cheng Y, Duan H, Zhang F, Wang L, Jin Y, Cao J, Wang Y, Liu B.   +11 more
europepmc   +1 more source

Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccine. [PDF]

NPJ Vaccines
Yamada M, Tazawa H, Suemori K, Okada N, Kajiwara Y, Shoji R, Nagai Y, Inoue H, Hashimoto N, Kanaya N, Kikuchi S, Kuroda S, Michiue H, Urata Y, Kagawa S, Fujiwara T.   +15 more
europepmc   +1 more source

Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies. [PDF]

PLoS One
Zargaran H, Ghaemi A, Shenagari M, Samadi M.   +3 more
europepmc   +1 more source

Impact of SPP1 and HMOX1 Genes in Glioma: Correlations With Oncolytic Virus Infection, Adverse Prognosis and Increased Cell Proliferation. [PDF]

J Cell Mol Med
Cui C, Wu C, Zhang S, Yin X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncolytic virus preclinical toxicology studies

Journal of Applied Toxicology, 2022
AbstractWith the ever‐emerging concerns of patient safety during medical care, the search for treatments as safe as possible is a priority, especially when focusing on cancer treatment of which therapies often go hand in hand with severe side effects.
Agnija Rasa, Pēteris Alberts
openaire   +2 more sources

Oncolytic Virus Therapies

Pharmaceutical Patent Analyst, 2012
Oncolytic virus (OV) therapy currently represents one of the most promising approaches to cancer treatment for their dual anticancer mechanisms: direct lysis of cancer cells (oncolytic feature) and activation of the immunosystem (cancer vaccine aspect).
Franco Maria, Buonaguro, Maria Lina, Tornesello, Francesco, Izzo, Luigi, Buonaguro   +3 more
openaire   +2 more sources

Oncolytic Virus Therapy - Foreword

Current Cancer Drug Targets, 2007
We are very pleased and proud to be able to publish this special issue of Current Cancer Drug Targets devoted to oncolytic virus therapy covering basic and clinical research on adenovirus, vaccinia virus, herpes virus, and Newcastle disease virus. In these papers, we welcome the world's top authorities in the field who have generously contributed their
H, Kasuya, S, Takeda, S, Shimoyama, T, Shikano, N, Nomura, N, Kanazumi, S, Nomoto, H, Sugimoto, A, Nakao   +8 more
openaire   +2 more sources

Oncolytic Virus Immunotherapy for Melanoma

Current Treatment Options in Oncology, 2015
Melanoma is a type of skin cancer arising from melanocytes and is increasing in incidence. Although complete surgical excision of early stage lesions may be curative, metastatic melanoma continues to be a major therapeutic challenge. Advances in understanding the molecular pathways that promote tumorigenesis and the interactions between melanoma cells ...
Neal, Dharmadhikari, Janice M, Mehnert, Howard L, Kaufman   +2 more
openaire   +2 more sources